Assessing the Impact of Coronary Plaque on the Relative and Absolute Risk Reduction With Statin Therapy
- PMID: 34419396
- DOI: 10.1016/j.jcmg.2021.07.005
Assessing the Impact of Coronary Plaque on the Relative and Absolute Risk Reduction With Statin Therapy
Keywords: coronary artery calcium; coronary CT angiography; primary prevention; risk assessment; statins; subclinical atherosclerosis.
Conflict of interest statement
Funding Support and Author Disclosures Dr Blaha has received grants from National Institutes of Health, Food and Drug Administration, American Heart Association, Aetna, Amgen, and Novo Nordisk and is on advisory boards for Amgen, Sanofi, Regeneron, Novartis, Novo Nordisk, Bayer, Kaleido, 89Bio, Inozyme, and Kowa. Dr Daubert has reported that she has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Reduction of Myocardial Infarction and All-Cause Mortality Associated to Statins in Patients Without Obstructive CAD.JACC Cardiovasc Imaging. 2021 Dec;14(12):2400-2410. doi: 10.1016/j.jcmg.2021.05.022. Epub 2021 Jul 14. JACC Cardiovasc Imaging. 2021. PMID: 34274285
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
